Carrageenan-induced acute inflammation in the mouse air pouch synovial model. Role of tumour necrosis factor

被引:65
作者
Romano, M [1 ]
Faggioni, R [1 ]
Sironi, M [1 ]
Sacco, S [1 ]
Echtenacher, B [1 ]
DiSanto, E [1 ]
Salmona, M [1 ]
Ghezzi, P [1 ]
机构
[1] UNIV REGENSBURG,INST PATHOL,D-8400 REGENSBURG,GERMANY
关键词
air pouch; inflammation; tumour necrosis factor;
D O I
10.1080/09629359791901
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
WE used the mouse air pouch model of inflammation to study the interaction between cytokines, prostaglandin E(2) (PGE(2)) and cell migration during the various phases of acute local inflammation induced by carrageenan. In serum, the levels of interleukin 1 (IL-1), interleukin 6 (IL-6), tumour necrosis factor (TNF), serum amiloid-A (SAA) and Fe++ were never different from controls, indicating that no systemic inflammatory changes were induced Locally the exudate volume and the number of leukocytes recruited into the pouch increased progressively until 7 days after carrageenan. The same was true for PGE(2) production. We could not measure IL-1 but the production of IL-6 and TNF reached a maximum after 5-24 h then quickly decreased Anti-TNF antibodies inhibited cell migration by 50% 24 h after treatment. Pretreatment with interleukin 10 (IL-10) inhibited TNF production almost completely and cell migration by 60%. Carrageenan-induced inflammation was modulated by anti-inflammatory drugs. Pretreatment with dexamethasone (DEX) or indomethacin (INDO) inhibited cell migration and reduced the concentration of TNF in the exudate. Production of PGE(2) or vascular permeability did not correlate with the number of cells in the pouch. Local TNF seems to play an important role in this model, particularly for leukocyte migration in the first phase of the inflammatory process. In conclusion, the air pouch seems to be a good model for studying the regulation of the early events of local inflammation, particularly the role of cytokines and cell migration.
引用
收藏
页码:32 / 38
页数:7
相关论文
共 30 条
[1]  
BENTLER B, 1985, SCIENCE, V229, P869
[2]  
BRENNAN FM, 1989, LANCET, V2, P244
[3]  
CATHERINE G, 1993, J EXP MED, V177, P547
[4]  
DAMOTTA JIB, 1994, BRIT J PHARMACOL, V112, P111
[5]  
EDWARDS JCW, 1981, J PATHOL, V134, P147, DOI 10.1002/path.1711340205
[6]  
ELLIOTT MJ, 1993, ARTHRITIS RHEUM, V36, P1681, DOI 10.1002/art.23362
[7]   DEFECTIVE INFLAMMATORY RESPONSE IN INTERLEUKIN 6-DEFICIENT MICE [J].
FATTORI, E ;
CAPPELLETTI, M ;
COSTA, P ;
SELLITTO, C ;
CANTONI, L ;
CARELLI, M ;
FAGGIONI, R ;
FANTUZZI, G ;
GHEZZI, P ;
POLI, V .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (04) :1243-1250
[8]   PROTECTIVE EFFECT OF CHLORPROMAZINE ON ENDOTOXIN TOXICITY AND TNF PRODUCTION IN GLUCOCORTICOID-SENSITIVE AND GLUCOCORTICOID-RESISTANT MODELS OF ENDOTOXIC-SHOCK [J].
GADINA, M ;
BERTINI, R ;
MENGOZZI, M ;
ZANDALASINI, M ;
MANTOVANI, A ;
GHEZZI, P .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (06) :1305-1310
[9]  
HOPKINS SJ, 1988, CLIN EXP IMMUNOL, V73, P88
[10]   INTERLEUKIN-10 PROTECTS MICE FROM LETHAL ENDOTOXEMIA [J].
HOWARD, M ;
MUCHAMUEL, T ;
ANDRADE, S ;
MENON, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (04) :1205-1208